Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain

Prostate

Volumn 67, Issue 2, 2007, Pages 146-153

  Hahn, Junghyun ^a   Xiao, Wuhan ^a   Jiang, Feng ^a,d   Simone, Federico ^b   Thirman, Michael J ^b   Wang, Zhou ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; ELL; Growth suppression; Prostate cancer; U19 Eaf2

Indexed keywords

AMINO ACID; MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADVANCED CANCER; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CHROMOSOME TRANSLOCATION; COLONY FORMATION; CONTROLLED STUDY; ELL GENE; GENE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; U19 EAF2 GENE; XENOGRAFT;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HELA CELLS; HUMANS; MALE; PEPTIDE MAPPING; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ELONGATION FACTORS; TRANSFECTION;

EID: 33846594230     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20481     Document Type: Article

References (23)

1. Chang CS, Kokontis J, Liao ST. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988;240:324-326.
2. Zhou ZX, Wong CI, Sar M, Wilson EM. The androgen receptor: An overview. Recent Prog Horm Res 1994;49:249-274.
3. Wang Z, Tufts R, Haleem R, Cai X. Genes regulated by androgen in the rat ventral prostate. Proc Natl Acad Sci USA 1997;94: 12999-13004.
4. Jiang F, Wang Z. Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray. Endocrinology 2003;144:1257-1265.
5. Simone F, Luo RT, Polak PE, Kaberlein JJ, Thirman MJ. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood 2003;101:2355-2362.
6. Xiao W, Zhang Q, Jiang F, Pins M, Kozlowski JM, Wang Z. Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer. Cancer Res 2003;63: 4698-4704.
7. Li M, Wu X, Zhuang F, Jiang S, Jiang M, Liu YH. Expression of murine ELL-associated factor 2 (Eaf2) is developmentally regulated. Dev Dyn 2003;228:273-280.
8. Maurus D, Heligon C, Burger-Schwarzler A, Brandli AW, Kuhl M. Noncanonical Wnt-4 signaling and EAF2 are required for eye development in Xenopus laevis. EMBO J 2005;24:1181-1191.
9. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 1994;91: 12110-12114.
10. DiMartino JF, Miller T, Ayton PM, Landewe T, Hess JL, Cleary ML, Shilatifard A. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood 2000;12:3887-3893.
11. Lavau C, Luo RT, Du C, Thirman MJ. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci USA 2000;97:10984-10989.
12. Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S, Thirman MJ. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis. Mol Cell Biol 2001;21: 5678-5687.
13. Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 1996;271:1873-1876.
14. Mitani K, Yamagata T, Iida C, Oda H, Maki K, Ichikawa M, Asai T, Honda H, Kurokawa M, Hirai H. Nonredundant roles of the elongation factor MEN in postimplantation development. Biochem Biophys Res Commun 2000;279:563-567.
15. Eissenberg JC, Ma J, Gerber MA, Christensen A, Kennison JA, Shilatifard A. dELL is an essential RNA polymerase II elongation factor with a general role in development. Proc Natl Acad Sci USA 2002;15:9894-9899.
16. Khattak S, Im H, Park T, Ahnn J, Spoerel NA. dELL, a drosophila homologue of transcription elongation factor ELL (Eleven-nineteen Lysine rich Leukemia), is required for early development. Cell Biochem Funct 2002;20:119-127.
17. Johnstone RW, Gerber M, Landewe T, Tollefson A, Wold WS, Shilatifard A. Functional analysis of the leukemia protein ELL: Evidence for a role in the regulation of cell growth and survival. Mol Cell Biol 2001;21:1672-1681.
18. Polak PE, Simone F, Kaberlein JJ, Luo RT, Thirman MJ. ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia. Mol Biol Cell 2003;14:1517-1528. Erratum in: Mol Biol Cell 2003; May 14.
19. Simone F, Polak PE, Kaberlein JJ, Luo RT, Levitan DA, Thirman MJ. EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein. Blood 2001;98:201-209.
20. Gall JG. The centennial of the Cajal body. Nat Rev Mol Cell Biol 2003;4:975-980.
21. Cioce M, Lamond AI. Cajal bodies: A long history of discovery. Annu Rev Cell Dev Biol 2005;21:105-131.
22. Kong SE, Banks CA, Shilatifard A, Conaway JW, Conaway RC. ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL. Proc Natl Acad Sci USA 2005;102:10094-10098.
23. Xiao W, Jiang F, Wang Z. ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation. Prostate 2006;66:1-12.